(Q33393937)

26 July 2017

1 reference

title

The 'antiphospholipid syndrome' and the 'lupus anticoagulant'. (English)

1 reference

26 July 2017

1 reference

1 reference

Cameron JS

1

1 reference

26 July 2017

Frampton G

series ordinal

2

1 reference

26 July 2017

1 November 1990

1 reference

26 July 2017

1 reference

26 July 2017

4

1 reference

26 July 2017

6

1 reference

26 July 2017

663-678

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00858647

26 July 2017

0 references

cites work

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00858647

Recurrent ischemic attacks in two young adults with lupus anticoagulant

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00858647

Polyreactive autoantibodies are nephritogenic in murine lupus nephritis

21 January 2018

1 reference

12 December 2020

Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients

1 reference

12 December 2020

The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies

1 reference

12 December 2020

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

12 December 2020

Lupus nephritis: clinical and pathological correlation

1 reference

12 December 2020

Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants

1 reference

12 December 2020

The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactors

1 reference

12 December 2020

Anti-cardiolipin antibodies in neurological disorders: cross-reaction with anti-single stranded DNA activity

1 reference

12 December 2020

Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria.

1 reference

12 December 2020

Anticardiolipin antibodies in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Plasma exchange and the anticardiolipin syndrome in pregnancy

1 reference

12 December 2020

Lupus anticoagulant, thrombosis, and fetal loss

1 reference

12 December 2020

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

12 December 2020

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

1 reference

12 December 2020

Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity

1 reference

12 December 2020

Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion

1 reference

12 December 2020

Anticardiolipin response in acute infections

1 reference

12 December 2020

Thromboembolism in patients with the 'lupus'-type circulating anticoagulant

1 reference

12 December 2020

Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both?

1 reference

12 December 2020

Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

1 reference

12 December 2020

Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms.

1 reference

12 December 2020

Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal

1 reference

12 December 2020

The laboratory heterogeneity of lupus anticoagulants

1 reference

12 December 2020

Syndrome of the black swan

1 reference

12 December 2020

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

1 reference

12 December 2020

Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus

1 reference

12 December 2020

Investigations of the lupus-like inhibitor by-passing activity of platelets

1 reference

12 December 2020

Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium

1 reference

12 December 2020

Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times

1 reference

12 December 2020

Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus

1 reference

12 December 2020

Lupus anticoagulant in pregnancy

1 reference

12 December 2020

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

1 reference

12 December 2020

Anticardiolipin antibodies in patients with rheumatic diseases

1 reference

12 December 2020

Simultaneous lupus anticoagulant and anticardiolipin assays and clinical detection of antiphospholipids

1 reference

12 December 2020

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

12 December 2020

Anticardiolipin antibodies in lyme disease

1 reference

12 December 2020

The lupus anticoagulant

1 reference

12 December 2020

Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986

1 reference

12 December 2020

Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies

1 reference

12 December 2020

A new type of coagulation inhibitor

1 reference

12 December 2020

Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis

1 reference

12 December 2020

Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia

1 reference

12 December 2020

Atypical lupus with special reference to ANA negative lupus and lupus subsets

1 reference

12 December 2020

Chorea and systemic lupus erythematosus with circulating anticoagulant. 3 cases

1 reference

12 December 2020

The "primary" antiphospholipid syndrome: major clinical and serological features.

1 reference

12 December 2020

A clinical study of the lupus anticoagulant

1 reference

12 December 2020

High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus

1 reference

12 December 2020

IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes

1 reference

12 December 2020

Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases

1 reference

12 December 2020

Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis

1 reference

12 December 2020

Obstetric complications associated with the lupus anticoagulant

1 reference

12 December 2020

The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus.

1 reference

12 December 2020

Pregnancy and antibodies to phospholipids

1 reference

12 December 2020

Thrombotic and hemorrhagic complications in children with the lupus anticoagulant.

1 reference

12 December 2020

Allograft membranous glomerulonephritis and renal-vein thrombosis in a patient with a lupus anticoagulant factor

1 reference

12 December 2020

The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus

1 reference

12 December 2020

Immunological specificity and mechanism of action of IgG lupus anticoagulants

1 reference

12 December 2020

Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome

1 reference

12 December 2020

Clinical and immunologic features of livedo reticularis in lupus: a case-control study

1 reference

12 December 2020

IgG binding to endothelial cells in systemic lupus erythematosus

1 reference

12 December 2020

High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population

1 reference

12 December 2020

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

1 reference

12 December 2020

Endothelial prostacyclin release in systemic lupus erythematosus

1 reference

12 December 2020

Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus

1 reference

12 December 2020

Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus

1 reference

12 December 2020

Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature.

1 reference

12 December 2020

Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals

1 reference

12 December 2020

Screening for the lupus anticoagulant

1 reference

12 December 2020

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

12 December 2020

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

1 reference

12 December 2020

Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure

1 reference

12 December 2020

A DNA antigen that reacts with antisera to cardiolipin

1 reference

12 December 2020

Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage

1 reference

12 December 2020

Decidual vasculopathy of the placenta in lupus erythematosus

1 reference

12 December 2020

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

1 reference

12 December 2020

Intrauterine death and circulating anticoagulant ("antithromboplastin")

1 reference

12 December 2020

Lupus anticoagulant and pregnancy

1 reference

12 December 2020

Detection of lupus anticoagulant in patients attending an anticoagulation clinic

1 reference

12 December 2020

Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus

1 reference

12 December 2020

False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abort

1 reference

12 December 2020

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients

1 reference

12 December 2020

Antibody to cardiolipin, lupus anticoagulant, and fetal death.

1 reference

12 December 2020

1 reference

12 December 2020

Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant

1 reference

12 December 2020

Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant

1 reference

12 December 2020

Low-dose aspirin in pregnancy

1 reference

12 December 2020

Cofactor of the "lupus anticoagulant".

1 reference

12 December 2020

Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus

1 reference

12 December 2020

Renal thrombotic microvascular disease associated with lupus anticoagulant

1 reference

12 December 2020

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

1 reference

12 December 2020

Myocardial infarction and antiphospholipid antibodies in SLE and related disorders

1 reference

12 December 2020

Anticoagulant activity of anticardiolipin antibodies

1 reference

12 December 2020

Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.

1 reference

12 December 2020

Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas

1 reference

12 December 2020

Monoclonal anti-cardiolipin antibodies bind to DNA

1 reference

12 December 2020

Binding specificity of lupus anticoagulants and anticardiolipin antibodies

1 reference

12 December 2020

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

12 December 2020

The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus

1 reference

12 December 2020

Acquired inhibitors of blood coagulation

1 reference

12 December 2020

Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant

1 reference

12 December 2020

Neonatal lupus erythematosus with a high anticardiolipin antibody titer. Unusual variant of neonatal lupus erythematosus or early-onset systemic lupus erythematosus?

1 reference

12 December 2020

Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant

1 reference

12 December 2020

IIIrd International Symposium on Anti-Phospholipid Antibodies. Kingston, Jamaica, January 5-8, 1988. Abstracts

1 reference

12 December 2020

Solid-phase anti-cardiolipin test revisited

1 reference

12 December 2020

Anticardiolipin antibody

1 reference

12 December 2020

The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA

1 reference

12 December 2020

Specificity of mouse hybridoma antibodies to DNA. II. Phospholipid reactivity and biological false positive serological test for syphilis

1 reference

12 December 2020

Coronary artery bypass graft failure--an autoimmune phenomenon?

1 reference

12 December 2020

Reduced prostacyclin activity in systemic lupus erythematosus

1 reference

12 December 2020

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

1 reference

12 December 2020

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

12 December 2020

Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone

1 reference

12 December 2020

THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS

1 reference

12 December 2020

The relationship between lupus anticoagulants and antibodies to phospholipid

1 reference

12 December 2020

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion

1 reference

12 December 2020

Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis

1 reference

12 December 2020

Antiphospholipid antibodies: more than just a disease marker?

1 reference

12 December 2020

Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity

1 reference

12 December 2020

Platelet-associated DNA and anti-DNA antibody in systemic lupus erythematosus with nephritis

1 reference

12 December 2020

Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant

1 reference

12 December 2020

The lupus coagulation inhibitor and venous thrombosis: a report of four cases

1 reference

12 December 2020

"Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation

1 reference

12 December 2020

Anticardiolipin antibodies and prostacyclin synthesis

1 reference

12 December 2020

Anticardiolipin antibodies: a risk factor for venous and arterial thrombosis

1 reference

12 December 2020

Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.

1 reference

12 December 2020

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

12 December 2020

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

1 reference

12 December 2020

Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus

1 reference

12 December 2020

Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

12 December 2020

Possible relationship between lupus inhibitor and recurrent abortion in young women

1 reference

12 December 2020

Anti-phospholipid antibodies

1 reference

12 December 2020

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study

1 reference

12 December 2020

Platelet and plasma serotonin concentrations in glomerulonephritis, II

1 reference

12 December 2020

Pregnancy and lupus: prognostic indicators and response to treatment

1 reference

12 December 2020

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

1 reference

12 December 2020

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

12 December 2020

Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane

1 reference

12 December 2020

Thrombosis in patients with the lupus anticoagulant

1 reference

12 December 2020

Prosthetic graft thrombosis associated with lupus anticoagulant

1 reference

12 December 2020

Crossreactivity of antiphospholipid antibodies

1 reference

12 December 2020

Affinity purified anti-cardiolipin and anti-DNA antibodies.

1 reference

12 December 2020

Multiple thromboses in systemic lupus erythematosus

1 reference

12 December 2020

Antiphospholipid antibodies and disease.

1 reference

12 December 2020

The anticardiolipin syndrome

1 reference

12 December 2020

The lupus anticoagulant and its role in thrombosis

1 reference

12 December 2020

THROMBOTIC TENDENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

12 December 2020

The clotting defect in SLE.

1 reference

12 December 2020

Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results

1 reference

12 December 2020

Acute renal failure in systemic lupus erythematosus

1 reference

12 December 2020

Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis

1 reference

12 December 2020

Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis

1 reference

12 December 2020

Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity?

1 reference

12 December 2020

Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus

1 reference

12 December 2020

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-1990. A 38-year-old woman with fever, skin lesions, thrombocytopenia, and venous thromboses

1 reference

12 December 2020

Fetal loss treatment in patients with antiphospholipid antibodies.

1 reference

12 December 2020

Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids

1 reference

12 December 2020

Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00858647

1 reference

Dimensions Publication ID

26 July 2017

1046344654

0 references

Fatcat ID

release_xqi5urzuzvdbzn4ifaxn4ewfxe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xqi5urzuzvdbzn4ifaxn4ewfxe

24 November 2022

mapped directly with Wikidata item

1 reference